elotuzumab 400 MG Injection
- RxCUI
- 1726117
- RxNorm name
- elotuzumab 400 MG Injection
- Display name
- elotuzumab 400 MG Injection
- Full name
- elotuzumab 400 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761035 | Empliciti | elotuzumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EMPLICITI | ELOTUZUMAB | E.R. Squibb & Sons, L.L.C. | 80686b7e-f6f4-4154-b5c0-c846425e2d91 | 2022-03-22 | Warnings, Adverse reactions | 1726117 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 80686b7e-f6f4-4154-b5c0-c846425e2d91 | elotuzumab 400 MG Injection [PSN] · elotuzumab 400 MG Injection [SCD] | 2 | 13 | These highlights do not include all the information needed to use EMPLICITI safely and effectively. See full prescribing information for EMPLICITI. EMPLICITI ® (elotuzumab) for injection, for intravenous use Initial U.S. Approval: 2015 | 20220322 |